|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 1,560 USD | +4,00% |
|
0,00% | -35,27% |
| 15/05 | Acrivon Therapeutics annonce l'octroi d'incitations conformément à la règle de cotation 5635(c)(4) du Nasdaq | RE |
| 13/05 | Acrivon Therapeutics : réduction de la perte nette au premier trimestre | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4,00% | 0,00% | -9,30% | -25,36% | -35,27% | +23,81% | -86,78% | - | - | 66,77 M | |
| +0,55% | -0,14% | -3,62% | +16,74% | +4,02% | -1,10% | +13,47% | -22,41% | +203,69% | 48,22 Md | |
| -2,71% | -2,99% | -3,59% | +30,81% | +129,06% | +398,09% | +472,12% | +518,26% | - | 38,79 Md | |
| -0,71% | +9,45% | +12,71% | +47,91% | +3,53% | +27,90% | +7,89% | -6,65% | +202,91% | 38,41 Md | |
| -0,71% | -3,72% | +5,42% | +6,78% | +3,28% | +4,94% | +52,45% | -8,11% | +1 080,03% | 34,88 Md | |
| -2,41% | +1,96% | -0,76% | -4,58% | +5,70% | +11,68% | +38,17% | -16,37% | +153,95% | 29,19 Md | |
| -0,66% | -2,73% | +2,81% | +37,30% | +2,07% | +35,50% | +122,17% | +224,55% | - | 16 Md | |
| -0,19% | -3,93% | -11,31% | +10,19% | - | - | - | - | - | 16,05 Md | |
| +2,13% | +0,96% | +0,70% | +19,56% | +10,87% | +3,97% | +17,41% | -32,18% | +78,88% | 13,53 Md | |
| -3,15% | -6,14% | -8,47% | +40,37% | -13,07% | -4,82% | -36,90% | -35,10% | +108,76% | 12,22 Md | |
| +0,07% | +0,73% | +1,85% | +31,12% | +22,67% | +31,43% | -10,95% | -40,04% | +156,16% | 11,24 Md | |
| -0,71% | +2,93% | +0,08% | +39,26% | +15,74% | +38,32% | +14,55% | -43,86% | +168,58% | 11,12 Md | |
| +1,40% | -0,09% | -15,67% | +8,59% | -9,72% | +77,61% | +551,68% | +282,75% | +2 422,04% | 10,64 Md | |
| +0,01% | -0,13% | +0,90% | +66,08% | +77,68% | +255,26% | +534,99% | - | - | 10,07 Md | |
| -1,98% | -6,96% | +21,98% | +23,06% | +26,87% | +19,83% | +20,23% | -63,11% | - | 8,92 Md | |
| -3,19% | -2,42% | +0,50% | +34,47% | +51,45% | +145,74% | +612,33% | +168,53% | - | 8,51 Md | |
| +5,25% | -2,63% | -33,39% | -27,62% | -31,12% | +26,63% | +38,23% | +44,12% | +44,42% | 9,06 Md | |
| -0,75% | -3,26% | -4,08% | -5,76% | +3,65% | +464,82% | +1 973,22% | +37,43% | - | 8,52 Md | |
| +2,25% | +3,04% | +5,56% | +23,59% | -10,58% | -19,48% | -18,67% | -27,75% | +37,34% | 8,75 Md | |
| -2,99% | -8,85% | -11,63% | +24,28% | +28,92% | +133,50% | +320,06% | +67,18% | - | 8,25 Md | |
| Moyenne | -0,01% | -1,31% | -2,47% | +19,84% | +15,04% | +88,09% | +243,98% | +61,60% | +423,34% | 17,12 Md | |
| Moyenne pondérée par Capi. | -0,17% | -0,40% | -0,61% | +22,23% | +22,41% | +86,59% | +184,62% | +78,12% | +406,20% |
- Bourse
- Actions
- Action ACRV
- Secteur Acrivon Therapeutics, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
